ArticleClinical oral investigations2025
Risk of bisphosphonate-related osteonecrosis of the jaw in implants vs. extractions: a nationwide population-based study.
Article in Clinical oral investigations, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A scientometric study on research trends and characteristics of medication-related osteonecrosis of the jaw.Journal of dental sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectivesThis study aimed to investigate the incidence of and factors associated with bisphosphonate-related osteonecrosis of the jaw (BRONJ) after dental procedures in South Korean patients with osteoporosis who use bisphosphonates, using a nationwide population-based approach. MATERIALS AND
methodsThe study utilised the National Health Insurance Service- National Health Information Database (NHIS-NHID), which covers the entire South Korean population. Patients diagnosed with osteoporosis between 2010 and 2018 were included, excluding those with malignant neoplasms, Paget's disease, or multiple myeloma. BRONJ cases were identified based on diagnostic codes, multiple outpatient visits or hospitalisation, and ONJ-specific treatments. Variables included age, sex, medications, and dental-related clinical information. Multiple logistic regression was used to determine the odds ratios for BRONJ incidence after dental treatment.
resultsAmong 57,572 patients, 250 developed BRONJ after dental treatment. The overall BRONJ incidence was 0.43%, with an incidence of 0.85% in extraction, 0.27% in periodontal treatment, and 0.13% in implant surgery. Implant surgeries (odds ratio = 0.15) and periodontal treatments (odds ratio = 0.32) had a significantly lower association with BRONJ compared to tooth extraction. Increasing age and longer duration of bisphosphonate use were associated with a higher incidence of BRONJ, but longer drug holidays were associated with a lower incidence of BRONJ.
conclusionImplant surgeries and periodontal treatments had a lower association with BRONJ compared to extraction. A longer bisphosphonate medication duration showed a higher association with possible BRONJ. CLINICAL RELEVANCE: This study suggests that tooth extraction is more strongly associated with BRONJ compared to implant surgery or periodontal treatment. To minimise the incidence of BRONJ, it is important to consider patient age and duration of bisphosphonate treatment.
Indexed as
Identifiers
40601138What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.